This report, from Stratview Research, studies the molecular diagnostics market over the trend period of 2014 to 2017 and forecast period of 2018 to 2025. The report provides detailed insights into the market dynamics to enable informed business decision making and growth strategy formulation based on the opportunities present in the market.
Salient Features of the Report
The Research Report offers an in-depth view of the market, its health and growth, the factors shaping the industry, the competitive dynamics and a glimpse of the future.
The following are the key features of the report:
- Strategic segmentation
- Market analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis
- Detailed Competitive Rivalry landscaping
- Market trend and forecast analysis
- Future Growth Boulevards
Get a free sample of the report:https://www.stratviewresearch.com/Request-Sample/417/molecular-diagnostics-market.html
The Global Molecular Diagnostics Market: Highlights
Why clinical molecular diagnostics is gaining clinical importance? Compared with conventional culture-based techniques, molecular diagnostic approaches provide substantially more rapid and specific information on organism identification and on the presence of resistance mechanisms. Such method enhances antimicrobial stewardship and decreases ‘time to appropriate antibiotics’, one of the most important factors in improving the prognosis of patients with life-threatening infections and improves DALY.
Molecular diagnostics of infectious diseases especially nucleic-acid-based processes, are the fastest growing field in clinical laboratory diagnostics. It involves stepwise replacing or complementing culture-based, biochemical, and immunological assays in microbiology laboratories. The first-generation nucleic acid assays were mono-parametric such as conventional tests, determining only a single parameter. With the introduction of advanced technologies such as microarrays, multiplex nucleic acid amplification techniques, or mass spectrometry, have actually reduced contamination risk while increasing the turnaround time (TAT) of results.
Get a TOC of the report:https://www.stratviewresearch.com/toc/417/molecular-diagnostics-market.html
Danaher Corporation (US), Becton, Dickinson and Company (US), Abbott Laboratories (US), Becton, Dickinson and Company and Biomérieux SA and few others are leading the global clinical microbiology market.
Comprehensive Market Coverage
Click Here for Other Reports from Stratview Research in the Healthcare & Life Science Industry: https://www.stratviewresearch.com/market-reports/Healthcare-and-Life-Sciences.html